CORT icon

Corcept Therapeutics
CORT

Overview Fund Activity

416 hedge funds and large institutions have $5.87B invested in Corcept Therapeutics in 2025 Q2 according to their latest regulatory filings, with 70 funds opening new positions, 152 increasing their positions, 155 reducing their positions, and 63 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
416
Holders Change
–
Holders Change %
0%
% of All Funds
5.58%
Holding in Top 10
6
Holding in Top 10 Change
-10
Holding in Top 10 Change %
-62.5%
% of All Funds
0.08%
New
70
Increased
152
Reduced
155
Closed
63
Calls
$51.5M
Puts
$84.9M
Net Calls
-$33.3M
Net Calls Change
+$109M

Top Buyers

1
LS
Livforsakringsbolaget Skandia
Sweden
$82.2M
2
ClearBridge Investments
ClearBridge Investments
New York
$85.7M
3
TD Asset Management
TD Asset Management
Ontario, Canada
$60.2M
4
EIP
Epoch Investment Partners
New York
$56.2M
5
T. Rowe Price Investment Management
T. Rowe Price Investment Management
Maryland
$41.6M

Top Sellers

1
BlackRock
BlackRock
New York
$920M
2
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
$33.4M
3
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
$57.9M
4
State Street
State Street
Massachusetts
$218M
5
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$23.3M
Name Holding Trade Value Shares
Change 		Shares
Change %
SSA
476
Schonfeld Strategic Advisors
New York
– -$11.4K -100 Closed
SIS
477
Strategic Investment Solutions
Illinois
– -$11.4K -100 Closed
SC
478
Stephens Consulting
Michigan
– -$2.86K -25 Closed
GFPC
479
Global Financial Private Client
Florida
– -$1.49K -13 Closed
16 17 18 19
20